A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

Researchers at Memorial Sloan Kettering Cancer Center gave the drug dostarlimab to 117 patients who have tumors that carry mismatch repair mutations, a rare condition that accounts for about 2% to 3% ...

Adding dostarlimab to platinum-based chemotherapy and niraparib improved PFS in patients with advanced ovarian cancer.

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, chemotherapy or radiation, the study found.

This phase 2 study builds on previous landmark research, in which colorectal cancer patients receiving the immunotherapy drug dostarlimab experienced complete tumor remission. In recognition of ...

A new study in the New England Journal of Medicine suggests that some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab.

(2016) for its economic base case. The NHS Clinical Lead for the Cancer Drugs Fund reported that 262 people have had dostarlimab with carboplatin and paclitaxel since it has been in the Cancer Drugs ...

For many, the word cancer brings images of hospitals, surgeries, and long, exhausting treatments. But a new drug therapy—dostarlimab—has quietly created a ripple of hope in the cancer world.

For a limited group of cancer patients who have solid ... Diaz Jr. and Dr. Andrea Cercek, decided to give dostarlimab, an immunotherapy drug, on its own. The result was stunning, and could bring ...